Evidence map›Paper›PMID 36325448›Full record

ArticleFrontiers in endocrinology2022

High initial FSH dosage reduces the number of available cleavage-stage embryos in a GnRH-antagonist protocol: Real-world data of 8,772 IVF cycles from China.

Xiu Luo, Li Pei, Yao He, Fujie Li, Wei Han, Shun Xiong, Shubiao Han, Jingyu Li, Xiaodong Zhang, Guoning Huang and 1 more

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiu LuoCenter for Reproductive Medicine, Chongqing Health Center for Women and Children, Chongqing, China.
Li PeiCenter for Reproductive Medicine, Chongqing Health Center for Women and Children, Chongqing, China.
Yao HeCenter for Reproductive Medicine, Chongqing Health Center for Women and Children, Chongqing, China.
Fujie LiCenter for Reproductive Medicine, Chongqing Health Center for Women and Children, Chongqing, China.
Wei HanCenter for Reproductive Medicine, Chongqing Health Center for Women and Children, Chongqing, China.
Shun XiongCenter for Reproductive Medicine, Chongqing Health Center for Women and Children, Chongqing, China.
Shubiao HanCenter for Reproductive Medicine, Chongqing Health Center for Women and Children, Chongqing, China.
Jingyu LiKey Laboratory of Human Embryo Engineering, Chongqing Maternal and Child Health Care Hospital, Chongqing, China.
Xiaodong ZhangKey Laboratory of Human Embryo Engineering, Chongqing Maternal and Child Health Care Hospital, Chongqing, China.
Guoning HuangCenter for Reproductive Medicine, Chongqing Health Center for Women and Children, Chongqing, China.
Hong YeCenter for Reproductive Medicine, Chongqing Health Center for Women and Children, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To evaluate the relationship between the initial follicle stimulating hormone (FSH) dose and the number of available cleavage-stage embryos in

Indexed as

Follicle Stimulating HormoneInfertilityFemaleFertilization in VitroGonadotropin-Releasing HormoneHormone AntagonistsHumansOvulation InductionPregnancyPregnancy RateFollicle Stimulating HormoneGonadotropin-Releasing HormoneHormone Antagonistscleavage-stage embryosFSH doseGnRH antagonistIn vitro fertilizationreal world evidence

Identifiers

PMID36325448
PMCPMC9618590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.